Improvement of Quality of Life by Switching from Oral Semaglutide to Tirzepatide in Patients with Type 2 Diabetes.

JMA J · 2025 · PMC12328484 · PMID 40786468

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The questionnaire regarding pain (Q12), which would typically be expected to worsen with the initiation of injectable medication, actually showed a trend toward improvement with the initiation of tirzepatide.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.